UK Life Sciences Company Directory

Antibody discovery biotech targeting GPCRs in inflammatory disease

DJS Antibodies is a biotechnology company developing monoclonal antibody therapeutics against G protein-coupled receptors and other previously intractable disease targets. Its proprietary antibody discovery platform enables the generation of first-in-class antibodies against transmembrane proteins that have…

Complex molecule synthesis and chemistry-driven cancer drug discovery

New Path Molecular Research is a Cambridge-based chemistry company spun out from the laboratory of Professor Steve Ley at the University of Cambridge. The company specialises in the synthesis of complex functional molecules, including natural products, macrocycles and peptides, using flow chemistry and…

Mycelium fermentation technology for whole-cut meat alternatives

Adamo Foods is an industrial biotechnology company developing whole-cut meat alternatives from fungal mycelium. Its proprietary MyoFerm fermentation process produces naturally fibrous fungal biomass that can be formed into steaks and fillets using a small number of added ingredients. The company combines bioreactor…

Oral delivery platform for biologics targeting inflammatory diseases

Intract Pharma is a biotechnology company developing proprietary formulation platforms for the oral delivery of complex biologics including monoclonal antibodies and proteins. The technology enables precision delivery to the colon for local and systemic immunomodulation, targeting gastrointestinal and systemic…

Mitochondrial sulfide-donor therapeutics for obesity and myopathies

MitoRx Therapeutics is a company developing first-in-class small molecule therapeutics that target mitochondrial sulfide signalling, a mechanism implicated in metabolic dysfunction and muscle disease. Its lead programme is an injectable mitochondria-targeted sulfide donor designed to achieve fat loss without lean mass…

mRNA vaccine manufacturer and R&D partner

Moderna is a company developing and manufacturing mRNA-based medicines and vaccines across infectious disease, oncology and rare disease. Its UK Innovation and Technology Centre, opened at Harwell in September 2025, is the first facility in the UK capable of onshore mRNA vaccine manufacturing, with capacity for up to…

AI-powered RNAi drug discovery company developing hepatic medicines

Tangram Therapeutics is a biotechnology company combining artificial intelligence and RNA interference to discover and develop novel medicines. Its proprietary chemistry platform silences disease-driving genes in hepatocytes, and its AI platform drives target identification and siRNA design. The pipeline includes…

Phosphoproteomics platform for kinase activity profiling and precision oncology

Kinomica is a UK precision medicine company developing phosphoproteomics technology for drug discovery and companion diagnostics. Its platform combines LC-MS/MS mass spectrometry with proprietary bioinformatics to measure kinase activity directly from patient samples, enabling drug target identification, monitoring of…

AI-enabled small molecule drug discovery

PharmEnable is a Cambridge-based drug discovery company developing novel small molecule therapeutics for targets that are inaccessible to biologics, including intracellular targets and those behind the blood-brain barrier. Its proprietary platform integrates AI and advanced medicinal chemistry to explore undercharted…

2D barcoded sample storage tubes and automated handling equipment

AltemisLab is a Cambridge-based manufacturer of 2D barcoded sample storage tubes, barcode readers, and automated capping and decapping equipment for laboratory sample management. Its range covers multiple storage formats including 96 SBS racks designed for short and long-term cryogenic storage. Complementary hardware…

In vivo cell reprogramming therapies for degenerative disease

Mogrify is a biotechnology company developing a novel class of in vivo reprogramming therapies for degenerative diseases. Its proprietary platforms use large-scale transcriptomic and epigenomic network data to predict the transcription factors required to convert mature human cells directly into target therapeutic…

Clinical-stage therapeutics for advanced liver disease

Yaqrit is a clinical-stage biotechnology company developing treatments for patients with advanced liver disease, including cirrhosis and acute-on-chronic liver failure. Its pipeline includes an oral ammonia scavenger for hepatic encephalopathy, an extracorporeal liver support device, and a microbiome-based…

Chromatography resins and process columns for biotherapeutic purification

BioToolomics is a UK manufacturer of process chromatography resins and disposable process columns for purification of biological therapeutics. It produces affinity, ion-exchange, hydrophobic interaction, mixed-mode, and gel filtration resin formats, alongside disposable columns from 5mm to 450mm internal diameter. Its…

GPR35 inhibitors for gastrointestinal cancer and inflammatory bowel disease

ThirtyFiveBio is a drug discovery company developing first-in-class small molecule inhibitors of GPR35, a genetically validated G protein-coupled receptor implicated in gastrointestinal disease. The company's approach targets GPR35 antagonism to prevent epithelial cell damage and dysfunction in the gut wall,…

Industry collaboration network for biopharmaceutical manufacturing and operations

BioPhorum is a UK-based membership organisation that brings together senior leaders and subject matter experts from global biopharmaceutical manufacturers, CDMOs, and suppliers to collaborate on shared operational and technology challenges. Working through structured groups covering drug substance, fill-finish, cell…

Early phase clinical trial CRO based at London Bridge

Richmond Pharmacology is a contract research organisation specialising in early phase and first-in-human clinical trials for pharmaceutical and biotech companies. Operating from hospital-adjacent facilities at London Bridge and St George's University London, the company has conducted over 20% of all UK Phase I studies…

AI-driven target discovery from human tissue omics

Relation is a platform biotechnology company integrating machine learning with single-cell and spatial multi-omics data derived directly from patient tissue to discover and validate novel drug targets. Its initial research focus is bone biology, with a proprietary observational study generating deeply characterised…

Web-based bioinformatics platform for microbial genomics and bioprocessing

MORF-Bio is a company developing a web-based software platform that makes microbial bioinformatics and bioprocess data analysis accessible to researchers and industry without specialist coding skills. Its tools cover microbial genome assembly and comparison, metabolic modelling, fermentation data visualisation and…

Scientific society for animal cell culture and biotechnology

ESACT-UK is a not-for-profit scientific society promoting knowledge exchange among scientists, engineers, and industrialists working in animal cell culture and related biotechnology. It covers the full cell culture production process, from cell line derivation and process development through to purification,…

Cell-based quality control materials for immunohistochemistry and ISH

HistoCyte Laboratories is a developer and manufacturer of cell-based quality control materials for immunohistochemistry and in situ hybridisation. Its products use proprietary cell line processing technology to produce formalin-fixed, paraffin-embedded control slides and blocks with reproducible, well-characterised…